The Valley Desk

NCT04268706 · Interventional trial

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

Overall registry status Active not recruiting

Phase 2

Conditions Hodgkin Disease Recurrent, Hodgkin Disease Refractory, Hodgkin Disease, Pediatric, Hodgkin Lymphoma, Adult

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov